AlphaCentric Advisors’s KalVista Pharmaceuticals KALV Stock Holding History

AlphaCentric Advisors’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell
2024 Q2	$29.4K	Sell
2024 Q1	$1.54M	Sell
2023 Q4	$1.68M	Buy
2023 Q3	$1.3M	Hold
2023 Q2	$1.22M	Buy